{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:29:45Z","timestamp":1790890185082,"version":"4.1.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10787-024-01636-3","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T03:57:02Z","timestamp":1736222222000},"page":"605-626","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Advancements in nose-to-brain drug targeting for Alzheimer\u2019s disease: a review of nanocarriers and clinical insights"],"prefix":"10.1007","volume":"33","author":[{"given":"Kumari","family":"Komal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debayan","family":"Sil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourabh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2042-1243","authenticated-orcid":false,"given":"Manish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"1636_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jddst.2017.09.021","volume":"43","author":"DMN Abouhussein","year":"2018","unstructured":"Abouhussein DMN, Khattab A, Bayoumi NA, Mahmoud AF, Sakr TM (2018) Brain targeted rivastigmine mucoadhesive thermosensitive In situ gel: optimization, in vitro evaluation, radiolabeling, in vivo pharmacokinetics and biodistribution. J Drug Deliv Sci Technol 43:129\u2013140","journal-title":"J Drug Deliv Sci Technol"},{"key":"1636_CR2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/cns.13035","volume":"24","author":"A Adlimoghaddam","year":"2018","unstructured":"Adlimoghaddam A, Neuendorff M, Roy B, Albensi BC (2018) A review of clinical treatment considerations of donepezil in severe Alzheimer\u2019s disease. CNS Neurosci Ther 24:876\u2013888","journal-title":"CNS Neurosci Ther"},{"key":"1636_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","volume":"281","author":"M Agrawal","year":"2018","unstructured":"Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, Alexander A (2018) Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release 281:139\u2013177","journal-title":"J Control Release"},{"key":"1636_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4155\/tde-2016-0022","volume":"7","author":"RU Agu","year":"2016","unstructured":"Agu RU (2016) Challenges in nasal drug absorption: how far have we come? Ther Deliv 7:495\u2013510","journal-title":"Ther Deliv"},{"key":"1636_CR5","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.4103\/1673-5374.241458","volume":"13","author":"A Alexander","year":"2018","unstructured":"Alexander A, Saraf S (2018) Nose-to-brain drug delivery approach: a key to easily accessing the brain for the treatment of Alzheimer\u2019s disease. Neural Regen Res 13:2102","journal-title":"Neural Regen Res"},{"key":"1636_CR6","doi-asserted-by":"publisher","first-page":"618411","DOI":"10.3389\/fphar.2021.618411","volume":"12","author":"MS Alqahtani","year":"2021","unstructured":"Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ (2021) Advances in oral drug delivery. Front Pharmacol 12:618411","journal-title":"Front Pharmacol"},{"key":"1636_CR7","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.3390\/app11094305","volume":"11","author":"L del Amo","year":"2021","unstructured":"del Amo L, Cano A, Ettcheto M, Souto EB, Espina M, Camins A, Garc\u00eda ML, S\u00e1nchez-L\u00f3pez E (2021) Surface functionalization of PLGA nanoparticles to increase transport across the BBB for Alzheimer\u2019s disease. Appl Sci 11:4305","journal-title":"Appl Sci"},{"key":"1636_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neulet.2011.03.084","volume":"496","author":"A Antonell","year":"2011","unstructured":"Antonell A, Balasa M, Oliva R, Llad\u00f3 A, Bosch B, Fabregat N, Fortea J, Molinuevo JL, S\u00e1nchez-Valle R (2011) A novel PSEN1 gene mutation (L235R) associated with familial early-onset Alzheimer\u2019s disease. Neurosci Lett 496:40\u201342","journal-title":"Neurosci Lett"},{"key":"1636_CR9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jalz.2017.02.001","volume":"13","author":"AS Association","year":"2017","unstructured":"Association AS (2017) Alzheimer\u2019s disease facts and figures. Alz Dementia 13:325\u2013373","journal-title":"Alz Dementia"},{"key":"1636_CR10","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/jphp.13098","volume":"71","author":"MF Attia","year":"2019","unstructured":"Attia MF, Anton N, Wallyn J, Omran Z, Vandamme TF (2019) An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol 71:1185\u20131198","journal-title":"J Pharm Pharmacol"},{"key":"1636_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/jpm10030114","volume":"10","author":"E Aus\u00f3","year":"2020","unstructured":"Aus\u00f3 E, G\u00f3mez-Vicente V, Esquiva G (2020) Biomarkers for Alzheimer\u2019s disease early diagnosis. J Personalized Med 10:114","journal-title":"J Personalized Med"},{"key":"1636_CR12","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.apsb.2022.07.003","volume":"13","author":"R Awad","year":"2023","unstructured":"Awad R, Avital A, Sosnik A (2023) Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders. Acta Pharmaceutica Sinica B 13:1866\u20131886","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"1636_CR13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2174\/156720112803529792","volume":"9","author":"S Bahadur","year":"2012","unstructured":"Bahadur S, Pathak K (2012) Buffered nanoemulsion for nose to brain delivery of ziprasidone hydrochloride: preformulation and pharmacodynamic evaluation. Curr Drug Deliv 9:596\u2013607","journal-title":"Curr Drug Deliv"},{"key":"1636_CR14","doi-asserted-by":"publisher","first-page":"103973","DOI":"10.1155\/2012\/103973","volume":"2012","author":"SS Banerjee","year":"2012","unstructured":"Banerjee SS, Aher N, Patil R, Khandare J (2012) Poly(ethylene glycol)-prodrug conjugates: concept, design, and applications. J Drug Deliv 2012:103973","journal-title":"J Drug Deliv"},{"key":"1636_CR15","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/j.febslet.2009.11.036","volume":"584","author":"FJ Barrantes","year":"2010","unstructured":"Barrantes FJ, Borroni V, Vall\u00e9s S (2010) Neuronal nicotinic acetylcholine receptor\u2013cholesterol crosstalk in Alzheimer\u2019s disease. FEBS Lett 584:1856\u20131863","journal-title":"FEBS Lett"},{"key":"1636_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pneurobio.2012.05.006","volume":"98","author":"G Barthet","year":"2012","unstructured":"Barthet G, Georgakopoulos A, Robakis NK (2012) Cellular mechanisms of \u03b3-secretase substrate selection, processing and toxicity. Prog Neurobiol 98:166\u2013175","journal-title":"Prog Neurobiol"},{"key":"1636_CR17","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","volume":"19","author":"MA Better","year":"2023","unstructured":"Better MA (2023) Alzheimer\u2019s disease facts and figures. Alz Dement 19:1598\u20131695","journal-title":"Alz Dement"},{"key":"1636_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1586\/14737159.5.5.661","volume":"5","author":"K Blennow","year":"2005","unstructured":"Blennow K (2005) CSF biomarkers for Alzheimer\u2019s disease: use in early diagnosis and evaluation of drug treatment. Expert Rev Mol Diagn 5:661\u2013672","journal-title":"Expert Rev Mol Diagn"},{"key":"1636_CR19","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1080\/17425247.2023.2286369","volume":"20","author":"G Botti","year":"2023","unstructured":"Botti G, Bianchi A, Dalpiaz A, Tedeschi P, Albanese V, Sorrenti M, Catenacci L, Bonferoni MC, Beggiato S, Pavan B (2023) Dimeric ferulic acid conjugate as a prodrug for brain targeting after nasal administration of loaded solid lipid microparticles. Expert Opin Drug Deliv 20:1657\u20131679","journal-title":"Expert Opin Drug Deliv"},{"key":"1636_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ejpb.2018.05.009","volume":"128","author":"V Bourganis","year":"2018","unstructured":"Bourganis V, Kammona O, Alexopoulos A, Kiparissides C (2018) Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics. Eur J Pharm Biopharm 128:337\u2013362","journal-title":"Eur J Pharm Biopharm"},{"key":"1636_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","volume":"243","author":"RM Califf","year":"2018","unstructured":"Califf RM (2018) Biomarker definitions and their applications. Exp Biol Med 243:213\u2013221","journal-title":"Exp Biol Med"},{"key":"1636_CR22","doi-asserted-by":"publisher","first-page":"2107.e7","DOI":"10.1016\/j.neurobiolaging.2011.05.023","volume":"32","author":"S Cervantes","year":"2011","unstructured":"Cervantes S, Samaranch L, Vidal-Taboada JM, Lamet I, Bullido MJ, Frank-Garc\u00eda A, Coria F, Lle\u00f3 A, Clarim\u00f3n J, Lorenzo E, Alonso E, S\u00e1nchez-Juan P, Rodr\u00edguez-Rodr\u00edguez E, Combarros O, Rosich M, Vilella E, Pastor P (2011) Genetic variation in APOE cluster region and Alzheimer\u2019s disease risk. Neurobiol Aging 32:2107.e7-2107.e17","journal-title":"Neurobiol Aging"},{"key":"1636_CR23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"C Cheignon","year":"2018","unstructured":"Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F (2018) Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol 14:450\u2013464","journal-title":"Redox Biol"},{"key":"1636_CR24","doi-asserted-by":"publisher","first-page":"20185","DOI":"10.1038\/srep20185","volume":"6","author":"SM Cho","year":"2016","unstructured":"Cho SM, Lee S, Yang S-H, Kim HY, Lee MJ, Kim HV, Kim J, Baek S, Yun J, Kim D, Kim YK, Cho Y, Woo J, Kim TS, Kim Y (2016) Age-dependent inverse correlations in CSF and plasma amyloid-\u03b2(1\u201342) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD mice. Sci Rep 6:20185","journal-title":"Sci Rep"},{"key":"1636_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fneur.2018.00325","volume":"9","author":"HS Cho","year":"2018","unstructured":"Cho HS, Huang LK, Lee YT, Chan L, Hong CT (2018) Suboptimal baseline serum vitamin B12 is associated with cognitive decline in people with Alzheimer\u2019s disease undergoing cholinesterase inhibitor treatment. Front Neurol 9:325","journal-title":"Front Neurol"},{"key":"1636_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","volume":"195","author":"TP Crowe","year":"2018","unstructured":"Crowe TP, Greenlee MHW, Kanthasamy AG, Hsu WH (2018) Mechanism of intranasal drug delivery directly to the brain. Life Sci 195:44\u201352","journal-title":"Life Sci"},{"key":"1636_CR27","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.2147\/DDDT.S86463","volume":"10","author":"WJ Deardorff","year":"2016","unstructured":"Deardorff WJ, Grossberg GT (2016) A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer\u2019s disease. Drug des Dev Ther 10:3267\u20133279","journal-title":"Drug des Dev Ther"},{"key":"1636_CR28","doi-asserted-by":"publisher","first-page":"102242","DOI":"10.1016\/j.jddst.2020.102242","volume":"61","author":"N Dhas","year":"2021","unstructured":"Dhas N, Mehta T (2021) Intranasal delivery of chitosan decorated PLGA core\/shell nanoparticles containing flavonoid to reduce oxidative stress in the treatment of Alzheimer\u2019s disease. J Drug Deliv Sci Technol 61:102242","journal-title":"J Drug Deliv Sci Technol"},{"key":"1636_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/pharmaceutics16010058","volume":"16","author":"S Dighe","year":"2024","unstructured":"Dighe S, Jog S, Momin M, Sawarkar S, Omri A (2024) Intranasal drug delivery by nanotechnology: advances in and challenges for Alzheimer\u2019s disease management. Pharmaceutics 16:58","journal-title":"Pharmaceutics"},{"key":"1636_CR30","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.colsurfb.2017.07.085","volume":"159","author":"JO Eloy","year":"2017","unstructured":"Eloy JO, Petrilli R, Trevizan LNF, Chorilli M (2017) Immunoliposomes: a review on functionalization strategies and targets for drug delivery. Colloids Surf B 159:454\u2013467","journal-title":"Colloids Surf B"},{"key":"1636_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/1871527317666180104122347","volume":"17","author":"LC Espinoza","year":"2018","unstructured":"Espinoza LC, Vacacela M, Clares B, Garcia ML, Fabrega M-J, Calpena AC (2018) Development of a nasal donepezil-loaded microemulsion for the treatment of Alzheimer\u2019s disease: in vitro and ex vivo characterization. CNS Neurol Disord Drug Targets 17:43\u201353","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1636_CR32","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s40120-023-00541-1","volume":"12","author":"A Esquer","year":"2023","unstructured":"Esquer A, Blanc F, Collongues N (2023) Immunotherapies targeting amyloid and tau protein in Alzheimer\u2019s disease: should we move away from diseases and focus on biological targets? A systematic review and expert opinion. Neurol Therapy 12:1883\u20131907","journal-title":"Neurol Therapy"},{"key":"1636_CR33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13346-021-00940-7","volume":"11","author":"LC Fonseca","year":"2021","unstructured":"Fonseca LC, Lopes JA, Vieira J, Viegas C, Oliveira CS, Hartmann RP, Fonte P (2021) Intranasal drug delivery for treatment of Alzheimer\u2019s disease. Drug Deliv Transl Res 11:411\u2013425","journal-title":"Drug Deliv Transl Res"},{"key":"1636_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13195-022-01146-w","volume":"15","author":"L Frings","year":"2023","unstructured":"Frings L, Blazhenets G, Binder R, Bormann T, Hellwig S, Meyer PT (2023) More extensive hypometabolism and higher mortality risk in patients with right- than left-predominant neurodegeneration of the anterior temporal lobe. Alz Res Therapy 15:11","journal-title":"Alz Res Therapy"},{"key":"1636_CR35","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/diagnostics12040796","volume":"12","author":"L Giampietri","year":"2022","unstructured":"Giampietri L, Belli E, Beatino MF, Giannoni S, Palermo G, Campese N, Tognoni G, Siciliano G, Ceravolo R, de Luca C, Baldacci F (2022) Fluid biomarkers in Alzheimer\u2019s disease and other neurodegenerative disorders: toward integrative diagnostic frameworks and tailored treatments. Diagnostics 12:796","journal-title":"Diagnostics"},{"key":"1636_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1478-811X-12-23","volume":"12","author":"JA Godoy","year":"2014","unstructured":"Godoy JA, Rios JA, Zolezzi JM, Braidy N, Inestrosa NC (2014) Signaling pathway cross talk in Alzheimer\u2019s disease. Cell Commun Signal 12:23","journal-title":"Cell Commun Signal"},{"key":"1636_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ijdevneu.2004.07.013","volume":"22","author":"J G\u00f6tz","year":"2004","unstructured":"G\u00f6tz J, Schild A, Hoerndli F, Pennanen L (2004) Amyloid-induced neurofibrillary tangle formation in Alzheimer\u2019s disease: insight from transgenic mouse and tissue-culture models. Int J Dev Neurosci 22:453\u2013465","journal-title":"Int J Dev Neurosci"},{"key":"1636_CR38","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.pharmthera.2012.03.003","volume":"134","author":"S Grassin-Delyle","year":"2012","unstructured":"Grassin-Delyle S, Buenestado A, Naline E, Faisy C, Blouquit-Laye S, Couderc L-J, le Guen M, Fischler M, Devillier P (2012) Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacol Ther 134:366\u2013379","journal-title":"Pharmacol Ther"},{"key":"1636_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000337386","volume":"33","author":"H Gr\u00f8nning","year":"2012","unstructured":"Gr\u00f8nning H, Rahmani A, Gyllenborg J, Dessau R, H\u00f8gh P (2012) Does Alzheimer\u2019s disease with early onset progress faster than with late onset? A case-control study of clinical progression and cerebrospinal fluid biomarkers. Dement Geriatr Cogn Disord 33:111\u2013117","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1636_CR40","doi-asserted-by":"publisher","first-page":"S611","DOI":"10.3233\/JAD-179935","volume":"64","author":"W Gulisano","year":"2018","unstructured":"Gulisano W, Maugeri D, Baltrons MA, F\u00e0 M, Amato A, Palmeri A, D\u2019Adamio L, Grassi C, Devanand DP, Honig LS, Puzzo D, Arancio O (2018) Role of amyloid-\u03b2 and tau proteins in Alzheimer\u2019s disease: confuting the amyloid cascade. J Alzheimers Dis 64:S611\u2013S631","journal-title":"J Alzheimers Dis"},{"key":"1636_CR41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0009-9120(01)00227-2","volume":"34","author":"M Haidari","year":"2001","unstructured":"Haidari M, Javadi E, Sadeghi B, Hajilooi M, Ghanbili J (2001) Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem 34:309\u2013315","journal-title":"Clin Biochem"},{"key":"1636_CR42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.molliq.2018.01.123","volume":"255","author":"MF Haider","year":"2018","unstructured":"Haider MF, Khan S, Gaba B, Alam T, Baboota S, Ali J, Ali A (2018) Optimization of rivastigmine nanoemulsion for enhanced brain delivery: in-vivo and toxicity evaluation. J Mol Liq 255:384\u2013396","journal-title":"J Mol Liq"},{"key":"1636_CR43","doi-asserted-by":"publisher","first-page":"7475","DOI":"10.3390\/ijms22147475","volume":"22","author":"T Hamano","year":"2021","unstructured":"Hamano T, Enomoto S, Shirafuji N, Ikawa M, Yamamura O, Yen S-H, Nakamoto Y (2021) Autophagy and tau protein. Int J Mol Sci 22:7475","journal-title":"Int J Mol Sci"},{"key":"1636_CR44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.exger.2009.10.010","volume":"45","author":"H Hampel","year":"2010","unstructured":"Hampel H, Blennow K, Shaw LM, Hoessler YC, Zetterberg H, Trojanowski JQ (2010) Total and phosphorylated tau protein as biological markers of Alzheimer\u2019s disease. Exp Gerontol 45:30\u201340","journal-title":"Exp Gerontol"},{"key":"1636_CR45","doi-asserted-by":"publisher","first-page":"127217","DOI":"10.1016\/j.ijbiomac.2023.127217","volume":"253","author":"SAAA Hard","year":"2023","unstructured":"Hard SAAA, Shivakumar HN, Redhwan MAM (2023) Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine. Int J Biol Macromol 253:127217","journal-title":"Int J Biol Macromol"},{"key":"1636_CR46","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.nbd.2008.11.009","volume":"33","author":"SS H\u00e9bert","year":"2009","unstructured":"H\u00e9bert SS, Horr\u00e9 K, Nicola\u00ef L, Bergmans B, Papadopoulou AS, Delacourte A, de Strooper B (2009) MicroRNA regulation of Alzheimer\u2019s amyloid precursor protein expression. Neurobiol Dis 33:422\u2013428","journal-title":"Neurobiol Dis"},{"key":"1636_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","volume":"11","author":"L Illum","year":"2000","unstructured":"Illum L (2000) Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11:1\u201318","journal-title":"Eur J Pharm Sci"},{"key":"1636_CR48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","volume":"39","author":"MT Islam","year":"2017","unstructured":"Islam MT (2017) Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res 39:73\u201382","journal-title":"Neurol Res"},{"key":"1636_CR49","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-013-1185-7","volume":"126","author":"CR Jack","year":"2013","unstructured":"Jack CR, Barrio JR, Kepe V (2013) Cerebral amyloid PET imaging in Alzheimer\u2019s disease. Acta Neuropathol 126:643\u2013657","journal-title":"Acta Neuropathol"},{"key":"1636_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0169-409X(01)00172-7","volume":"51","author":"N Jones","year":"2001","unstructured":"Jones N (2001) The nose and paranasal sinuses physiology and anatomy. Adv Drug Deliv Rev 51:5\u201319","journal-title":"Adv Drug Deliv Rev"},{"key":"1636_CR51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, J\u00f6nsson EG, Palotie A, Behrens TW, Magnusson OT, Kong A, Thorsteinsdottir U, Watts RJ, Stefansson K (2012) A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488:96\u201399","journal-title":"Nature"},{"key":"1636_CR52","unstructured":"Kalola UK, Nguyen H (2021) Galantamine"},{"key":"1636_CR53","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1586\/ern.11.155","volume":"11","author":"S Karantzoulis","year":"2011","unstructured":"Karantzoulis S, Galvin JE (2011) Distinguishing Alzheimer\u2019s disease from other major forms of dementia. Expert Rev Neurother 11:1579\u20131591","journal-title":"Expert Rev Neurother"},{"key":"1636_CR54","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11062-019-09823-7","volume":"51","author":"S Kaur","year":"2019","unstructured":"Kaur S, Dasgupta G, Singh S (2019) Altered neurochemistry in Alzheimer\u2019s disease: targeting neurotransmitter receptor mechanisms and therapeutic strategy. Neurophysiology 51:293\u2013309","journal-title":"Neurophysiology"},{"key":"1636_CR55","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3233\/JAD-150238","volume":"46","author":"TK Khan","year":"2015","unstructured":"Khan TK, Alkon DL (2015) Alzheimer\u2019s disease cerebrospinal fluid and neuroimaging biomarkers: diagnostic accuracy and relationship to drug efficacy. J Alzheimers Dis 46:817\u2013836","journal-title":"J Alzheimers Dis"},{"key":"1636_CR56","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","volume":"268","author":"AR Khan","year":"2017","unstructured":"Khan AR, Liu M, Khan MW, Zhai G (2017) Progress in brain targeting drug delivery system by nasal route. J Control Release 268:364\u2013389","journal-title":"J Control Release"},{"key":"1636_CR57","doi-asserted-by":"publisher","first-page":"101661","DOI":"10.1016\/j.jddst.2020.101661","volume":"57","author":"D Khunt","year":"2020","unstructured":"Khunt D, Polaka S, Shrivas M, Misra M (2020) Biodistribution and amyloid beta induced cell line toxicity study of intranasal Rivastigmine microemulsion enriched with fish oil and butter oil. J Drug Deliv Sci Technol 57:101661","journal-title":"J Drug Deliv Sci Technol"},{"key":"1636_CR58","volume-title":"Direct Nose-to-Brain Drug Delivery","author":"D Khunt","year":"2021","unstructured":"Khunt D, Misra M (2021) Chapter 1 - an overview of anatomical and physiological aspects of the nose and the brain. In: Pardeshi CV, Souto EB (eds) Direct Nose-to-Brain Drug Delivery. Academic Press, Cambridge"},{"key":"1636_CR59","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.comppsych.2015.07.002","volume":"62","author":"S Kim","year":"2015","unstructured":"Kim S, Kim MJ, Kim S, Kang HS, Lim SW, Myung W, Lee Y, Hong CH, Choi SH, Na DL, Seo SW, Ku BD, Kim SY, Kim SY, Jeong JH, Park SA, Carroll BJ, Kim DK (2015) Gender differences in risk factors for transition from mild cognitive impairment to Alzheimer\u2019s disease: a CREDOS study. Compr Psychiatry 62:114\u2013122","journal-title":"Compr Psychiatry"},{"key":"1636_CR60","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/med.21387","volume":"36","author":"CS Kue","year":"2016","unstructured":"Kue CS, Kamkaew A, Burgess K, Kiew LV, Chung LY, Lee HB (2016) Small molecules for active targeting in cancer. Med Res Rev 36:494\u2013575","journal-title":"Med Res Rev"},{"key":"1636_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2021.02.015","volume":"163","author":"P Kulkarni","year":"2021","unstructured":"Kulkarni P, Rawtani D, Barot T (2021) Design, development and in-vitro\/in-vivo evaluation of intranasally delivered Rivastigmine and N-Acetyl Cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer\u2019s disease. Eur J Pharm Biopharm 163:1\u201315","journal-title":"Eur J Pharm Biopharm"},{"key":"1636_CR62","volume-title":"Memantine. StatPearls","author":"B Kuns","year":"2024","unstructured":"Kuns B, Rosani A, Patel P, Varghese D (2024) Memantine. StatPearls. StatPearls Publishing, Treasure Island"},{"key":"1636_CR63","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.drudis.2015.02.009","volume":"20","author":"G Leyva-Gomez","year":"2015","unstructured":"Leyva-Gomez G, Cortes H, Magana JJ, Leyva-Garc\u00eda N, Quintanar-Guerrero D, Flor\u00e1n B (2015) Nanoparticle technology for treatment of Parkinson\u2019s disease: the role of surface phenomena in reaching the brain. Drug Discov Today 20:824\u2013837","journal-title":"Drug Discov Today"},{"key":"1636_CR64","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.etap.2012.04.012","volume":"34","author":"W Li","year":"2012","unstructured":"Li W, Zhou Y, Zhao N, Hao B, Wang X, Kong P (2012) Pharmacokinetic behavior and efficiency of acetylcholinesterase inhibition in rat brain after intranasal administration of galanthamine hydrobromide loaded flexible liposomes. Environ Toxicol Pharmacol 34:272\u2013279","journal-title":"Environ Toxicol Pharmacol"},{"key":"1636_CR65","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","volume":"64","author":"JJ Lochhead","year":"2012","unstructured":"Lochhead JJ, Thorne RG (2012) Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 64:614\u2013628","journal-title":"Adv Drug Deliv Rev"},{"key":"1636_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1081\/DDC-120001481","volume":"28","author":"PR Lockman","year":"2002","unstructured":"Lockman PR, Mumper RJ, Khan MA, Allen DD (2002) Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev Ind Pharm 28:1\u201313","journal-title":"Drug Dev Ind Pharm"},{"key":"1636_CR67","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3390\/nu9070725","volume":"9","author":"F Ma","year":"2017","unstructured":"Ma F, Wu T, Zhao J, Ji L, Song A, Zhang M, Huang G (2017) Plasma homocysteine and serum folate and vitamin B12 levels in mild cognitive impairment and Alzheimer\u2019s disease: a case-control study. Nutrients 9:725","journal-title":"Nutrients"},{"key":"1636_CR68","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.2174\/1389450121999201230203709","volume":"22","author":"S Mal","year":"2021","unstructured":"Mal S, Malik U, Pal D, Mishra A (2021) Insight \u03b3-secretase: structure, function, and role in Alzheimer\u2019s disease. Curr Drug Targets 22:1376\u20131403","journal-title":"Curr Drug Targets"},{"key":"1636_CR69","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jddst.2018.03.030","volume":"45","author":"MK Malaiya","year":"2018","unstructured":"Malaiya MK, Jain A, Pooja H, Jain A, Jain D (2018) Controlled delivery of rivastigmine using transdermal patch for effective management of Alzheimer\u2019s disease. J Drug Deliv Sci Technol 45:408\u2013414","journal-title":"J Drug Deliv Sci Technol"},{"key":"1636_CR70","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL (2015) Alzheimer\u2019s disease. Nat Rev Dis Prime 1:15056","journal-title":"Nat Rev Dis Prime"},{"key":"1636_CR71","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ejps.2012.12.007","volume":"48","author":"S Md","year":"2013","unstructured":"Md S, Khan RA, Mustafa G, Chuttani K, Baboota S, Sahni JK, Ali J (2013) Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model. Eur J Pharm Sci 48:393\u2013405","journal-title":"Eur J Pharm Sci"},{"key":"1636_CR72","first-page":"12","volume":"19","author":"CD Meletis","year":"2020","unstructured":"Meletis CD (2020) Alkyl-acylglycerols and the important clinical ramifications of raising plasmalogens in dementia and Alzheimer\u2019s disease. Integr Med (Encinitas) 19:12\u201316","journal-title":"Integr Med (Encinitas)"},{"key":"1636_CR73","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2147\/IJN.S151474","volume":"13","author":"Q Meng","year":"2018","unstructured":"Meng Q, Wang A, Hua H, Jiang Y, Wang Y, Mu H, Wu Z, Sun K (2018) Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer\u2019s disease. Int J Nanomed 13:705\u2013718","journal-title":"Int J Nanomed"},{"key":"1636_CR74","volume-title":"Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents","author":"V Mishra","year":"2020","unstructured":"Mishra V, Yadav N, Saraogi GK (2020) Chapter 14 - targeting aspects for bioactive drugs. In: Singh MR, Singh D, Kanwar JR, Chauhan NS (eds) Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents. Academic Press, Cambridge"},{"key":"1636_CR75","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.2174\/138920112803341752","volume":"13","author":"A Misra","year":"2012","unstructured":"Misra A, Kher G (2012) Drug delivery systems from nose to brain. Curr Pharm Biotechnol 13:2355\u20132379","journal-title":"Curr Pharm Biotechnol"},{"key":"1636_CR76","doi-asserted-by":"publisher","first-page":"617588","DOI":"10.3389\/fnagi.2021.617588","volume":"13","author":"A Misrani","year":"2021","unstructured":"Misrani A, Tabassum S, Yang L (2021a) Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease. Front Aging Neurosci 13:617588","journal-title":"Front Aging Neurosci"},{"key":"1636_CR77","doi-asserted-by":"publisher","first-page":"617588","DOI":"10.3389\/fnagi.2021.617588","volume":"13","author":"A Misrani","year":"2021","unstructured":"Misrani A, Tabassum S, Yang L (2021) Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease. Front Aging Neurosci 13:617588","journal-title":"Front Aging Neurosci"},{"key":"1636_CR78","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ijbiomac.2019.07.003","volume":"137","author":"H Moulahoum","year":"2019","unstructured":"Moulahoum H, Sanli S, Timur S, Zihnioglu F (2019) Potential effect of carnosine encapsulated niosomes in bovine serum albumin modifications. Int J Biol Macromol 137:583\u2013591","journal-title":"Int J Biol Macromol"},{"key":"1636_CR79","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ejps.2016.05.012","volume":"92","author":"E Muntimadugu","year":"2016","unstructured":"Muntimadugu E, Dhommati R, Jain A, Challa VGS, Shaheen M, Khan W (2016) Intranasal delivery of nanoparticle encapsulated tarenflurbil: a potential brain targeting strategy for Alzheimer\u2019s disease. Eur J Pharm Sci 92:224\u2013234","journal-title":"Eur J Pharm Sci"},{"key":"1636_CR80","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1080\/10717544.2017.1309476","volume":"24","author":"EHS Nageeb","year":"2017","unstructured":"Nageeb EHS, Abd EA, Kassem MA, El-Nabarawi MA (2017) Electrosteric stealth Rivastigmine loaded liposomes for brain targeting: preparation, characterization, ex vivo, bio-distribution and in vivo pharmacokinetic studies. Drug Deliv 24:692\u2013700","journal-title":"Drug Deliv"},{"key":"1636_CR81","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.imlet.2014.10.001","volume":"162","author":"R Nezlin","year":"2014","unstructured":"Nezlin R (2014) Aptamers in immunological research. Immunol Lett 162:252\u20135","journal-title":"Immunol Lett"},{"key":"1636_CR82","doi-asserted-by":"publisher","first-page":"12050","DOI":"10.1038\/s41598-018-30487-6","volume":"8","author":"A Ng","year":"2018","unstructured":"Ng A, Tam WW, Zhang MW, Ho CS, Husain SF, McIntyre RS, Ho RC (2018) IL-1\u03b2, IL-6, TNF- \u03b1 and CRP in elderly patients with depression or Alzheimer\u2019s disease: systematic review and meta-analysis. Sci Rep 8:12050","journal-title":"Sci Rep"},{"key":"1636_CR83","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2217\/nmt-2020-0052","volume":"11","author":"K Nguyen","year":"2021","unstructured":"Nguyen K, Hoffman H, Chakkamparambil B, Grossberg GT (2021) Evaluation of Rivastigmine in Alzheimer\u2019s disease. Neurodegener Dis Manage 11:35\u201348","journal-title":"Neurodegener Dis Manage"},{"key":"1636_CR84","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s11910-014-0500-6","volume":"14","author":"N Okamura","year":"2014","unstructured":"Okamura N, Harada R, Furumoto S, Arai H, Yanai K, Kudo Y (2014) Tau PET imaging in Alzheimer\u2019s disease. Curr Neurol Neurosci Rep 14:500","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1636_CR85","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/molecules14093754","volume":"14","author":"Y Ozsoy","year":"2009","unstructured":"Ozsoy Y, Gungor S, Cevher E (2009) Nasal delivery of high molecular weight drugs. Molecules 14:3754","journal-title":"Molecules"},{"key":"1636_CR86","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1517\/17425247.2013.790887","volume":"10","author":"CV Pardeshi","year":"2013","unstructured":"Pardeshi CV, Belgamwar VS (2013) Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood\u2013brain barrier: an excellent platform for brain targeting. Expert Opin Drug Deliv 10:957\u2013972","journal-title":"Expert Opin Drug Deliv"},{"key":"1636_CR87","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/membranes11050343","volume":"11","author":"R Pereira","year":"2021","unstructured":"Pereira R, Silva SG, Pinheiro M, Reis S, Vale ML (2021) Current status of amino acid-based permeation enhancers in transdermal drug delivery. Membranes 11:343","journal-title":"Membranes"},{"key":"1636_CR88","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/pharmaceutics14030588","volume":"14","author":"PC Pires","year":"2022","unstructured":"Pires PC, Rodrigues M, Alves G, Santos AO (2022) Strategies to improve drug strength in nasal preparations for brain delivery of low aqueous solubility drugs. Pharmaceutics 14:588","journal-title":"Pharmaceutics"},{"key":"1636_CR89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejmech.2015.04.040","volume":"97","author":"AM Pisoschi","year":"2015","unstructured":"Pisoschi AM, Pop A (2015) The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem 97:55\u201374","journal-title":"Eur J Med Chem"},{"key":"1636_CR90","doi-asserted-by":"publisher","first-page":"101463","DOI":"10.1016\/j.rechem.2024.101463","volume":"7","author":"A Puri","year":"2024","unstructured":"Puri A, Mohite P, Khan S, Singh S (2024) Breaking the barriers in management of Alzheimer\u2019s disease through cationic nanoformulation: a review. Results Chem 7:101463","journal-title":"Results Chem"},{"key":"1636_CR91","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.2174\/092986712800784702","volume":"19","author":"MJ Rabanel","year":"2012","unstructured":"Rabanel MJ, Aoun V, Elkin I, Mokhtar M, Hildgen P (2012) Drug-loaded nanocarriers: passive targeting and crossing of biological barriers. Curr Med Chem 19:3070\u20133102","journal-title":"Curr Med Chem"},{"key":"1636_CR92","doi-asserted-by":"publisher","first-page":"2000076","DOI":"10.1002\/adtp.202000076","volume":"4","author":"N Rabiee","year":"2021","unstructured":"Rabiee N, Ahmadi S, Afshari R, Khalaji S, Rabiee M, Bagherzadeh M, Fatahi Y, Dinarvand R, Tahriri M, Tayebi L (2021) Polymeric nanoparticles for nasal drug delivery to the brain: relevance to Alzheimer\u2019s disease. Adv Ther 4:2000076","journal-title":"Adv Ther"},{"key":"1636_CR93","doi-asserted-by":"publisher","first-page":"104756","DOI":"10.1016\/j.jddst.2023.104756","volume":"86","author":"M Raghav","year":"2023","unstructured":"Raghav M, Gupta V, Awasthi R, Singh A, Kulkarni GT (2023) Nose-to-brain drug delivery: challenges and progress towards brain targeting in the treatment of neurological disorders. J Drug Deliv Sci Technol 86:104756","journal-title":"J Drug Deliv Sci Technol"},{"key":"1636_CR94","doi-asserted-by":"publisher","first-page":"103087","DOI":"10.1016\/j.jddst.2021.103087","volume":"69","author":"SS Rajamma","year":"2022","unstructured":"Rajamma SS, Krishnaswami V, Prabu SL, Kandasamy R (2022) Geophila repens phytosome-loaded intranasal gel with improved nasal permeation for the effective treatment of Alzheimer\u2019s disease. J Drug Deliv Sci Technol 69:103087","journal-title":"J Drug Deliv Sci Technol"},{"key":"1636_CR95","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1208\/s12249-022-02209-9","volume":"23","author":"A Rajput","year":"2022","unstructured":"Rajput A, Butani S (2022) Donepezil HCl liposomes: development, characterization, cytotoxicity, and pharmacokinetic study. AAPS PharmSciTech 23:74","journal-title":"AAPS PharmSciTech"},{"key":"1636_CR96","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.3390\/pharmaceutics14091976","volume":"14","author":"TD Ribeiro","year":"2022","unstructured":"Ribeiro TD, S\u00e1bio RM, Luiz MT, de Souza LC, Fonseca-Santos B, Da Cides SLC, Fantini MC, Planeta CD, Chorilli M (2022) Curcumin-loaded mesoporous silica nanoparticles dispersed in thermo-responsive hydrogel as potential Alzheimer disease therapy. Pharmaceutics 14:1976","journal-title":"Pharmaceutics"},{"key":"1636_CR97","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1163\/138577209X12478283327236","volume":"12","author":"S Roy","year":"2009","unstructured":"Roy S, Pal K, Anis A, Pramanik K, Prabhakar B (2009) Polymers in mucoadhesive drug-delivery systems: a brief note. Des Monomers Polym 12:483\u2013495","journal-title":"Des Monomers Polym"},{"key":"1636_CR98","doi-asserted-by":"publisher","first-page":"111838","DOI":"10.1016\/j.colsurfb.2021.111838","volume":"205","author":"S Saini","year":"2021","unstructured":"Saini S, Sharma T, Jain A, Kaur H, Katare OP, Singh B (2021) Systematically designed chitosan-coated solid lipid nanoparticles of ferulic acid for effective management of Alzheimer\u2019s disease: a preclinical evidence. Colloids Surf B 205:111838","journal-title":"Colloids Surf B"},{"key":"1636_CR99","doi-asserted-by":"publisher","first-page":"103656","DOI":"10.1016\/j.jddst.2022.103656","volume":"75","author":"KT Sastri","year":"2022","unstructured":"Sastri KT, Gupta NVMS, Chakraborty S, Kumar H, Chand P, Balamuralidhara V, Gowda DV (2022) Nanocarrier facilitated drug delivery to the brain through intranasal route: a promising approach to transcend bio-obstacles and alleviate neurodegenerative conditions. J Drug Deliv Sci Technol 75:103656","journal-title":"J Drug Deliv Sci Technol"},{"key":"1636_CR100","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.3390\/ijms232112924","volume":"23","author":"U Sehar","year":"2022","unstructured":"Sehar U, Rawat P, Reddy AP, Kopel J, Reddy PH (2022) Amyloid beta in aging and Alzheimer\u2019s disease. Int J Mol Sci 23:12924","journal-title":"Int J Mol Sci"},{"key":"1636_CR101","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1517\/14656566.8.7.1011","volume":"8","author":"B Seltzer","year":"2007","unstructured":"Seltzer B (2007) Donepezil: an update. Expert Opin Pharmacother 8:1011\u20131023","journal-title":"Expert Opin Pharmacother"},{"key":"1636_CR102","first-page":"2088","volume":"46","author":"K Selvaraj","year":"2018","unstructured":"Selvaraj K, Gowthamarajan K, Karri VVSR (2018) Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting. Artif Cells Nanomed Biotechnol 46:2088\u20132095","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"1636_CR103","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3109\/10717544.2013.878857","volume":"22","author":"BM Shah","year":"2015","unstructured":"Shah BM, Misra M, Shishoo CJ, Padh H (2015) Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization. Drug Deliv 22:918\u2013930","journal-title":"Drug Deliv"},{"key":"1636_CR104","unstructured":"Shaji K, Jotheeswaran A, Girish N, Bharath S, Dias A, Pattabiraman M, Varghese M (2010) The dementia India report: prevalence, impact, costs and services for dementia. Alzheimer\u2019s and Related Disorders Society of India. 1\u201338"},{"key":"1636_CR105","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.2147\/IJN.S417928","volume":"18","author":"MK Shehata","year":"2023","unstructured":"Shehata MK, Ismail AA, Kamel MA (2023) Combined donepezil with astaxanthin via nanostructured lipid carriers effective delivery to brain for Alzheimer\u2019s disease in rat model. Int J Nanomed 18:4193\u20134227","journal-title":"Int J Nanomed"},{"key":"1636_CR106","doi-asserted-by":"publisher","first-page":"e1704007","DOI":"10.1002\/adma.201704007","volume":"30","author":"Z Shen","year":"2018","unstructured":"Shen Z, Song J, Yung BC, Zhou Z, Wu A, Chen X (2018) Emerging strategies of cancer therapy based on ferroptosis. Adv Mater 30:e1704007","journal-title":"Adv Mater"},{"key":"1636_CR107","volume-title":"Inflammation, Aging, and Oxidative Stress","author":"SK Singh","year":"2016","unstructured":"Singh SK, Castellani R, Perry G (2016) Oxidative stress and Alzheimer\u2019s disease. In: Bondy SC, Campbell A (eds) Inflammation, Aging, and Oxidative Stress. Springer International Publishing, Cham"},{"key":"1636_CR108","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.ultsonch.2014.03.025","volume":"21","author":"M Sivakumar","year":"2014","unstructured":"Sivakumar M, Tang SY, Tan KW (2014) Cavitation technology\u2013a greener processing technique for the generation of pharmaceutical nanoemulsions. Ultrason Sonochem 21:2069\u20132083","journal-title":"Ultrason Sonochem"},{"key":"1636_CR109","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","volume":"87","author":"JA Smith","year":"2012","unstructured":"Smith JA, Das A, Ray SK, Banik NL (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87:10\u201320","journal-title":"Brain Res Bull"},{"key":"1636_CR110","doi-asserted-by":"publisher","first-page":"105855","DOI":"10.1016\/j.jddst.2024.105855","volume":"98","author":"A Sonwani","year":"2024","unstructured":"Sonwani A, Pathak A, Jain K (2024) Nanocarriers-mediated nose-to-brain drug delivery: a novel approach for the management of Alzheimer\u2019s disease. J Drug Deliv Sci Technol 98:105855","journal-title":"J Drug Deliv Sci Technol"},{"key":"1636_CR111","doi-asserted-by":"publisher","first-page":"113320","DOI":"10.1016\/j.ejmech.2021.113320","volume":"216","author":"S Srivastava","year":"2021","unstructured":"Srivastava S, Ahmad R, Khare SK (2021) Alzheimer\u2019s disease and its treatment by different approaches: a review. Eur J Med Chem 216:113320","journal-title":"Eur J Med Chem"},{"key":"1636_CR112","doi-asserted-by":"publisher","first-page":"100134","DOI":"10.1016\/j.medidd.2022.100134","volume":"15","author":"A Sultana","year":"2022","unstructured":"Sultana A, Zare M, Thomas V, Kumar TSS, Ramakrishna S (2022) Nano-based drug delivery systems: conventional drug delivery routes, recent developments and future prospects. Med Drug Discov 15:100134","journal-title":"Med Drug Discov"},{"key":"1636_CR113","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3390\/pharmaceutics15051399","volume":"15","author":"R Tal\u00e9ns-Visconti","year":"2023","unstructured":"Tal\u00e9ns-Visconti R, De Juli\u00e1n-Ortiz JV, Vila-Bus\u00f3 O, Diez-Sales O, N\u00e1cher A (2023) Intranasal drug administration in Alzheimer-type dementia: towards clinical applications. Pharmaceutics 15:1399","journal-title":"Pharmaceutics"},{"key":"1636_CR114","volume-title":"Biomarkers in Trauma, Injury and Critical Care","author":"EP Thelin","year":"2023","unstructured":"Thelin EP, Lindblad C (2023) Cerebrospinal fluid as a platform for biomarker identification in traumatic brain injury. In: Rajendram R, Preedy VR, Patel VB (eds) Biomarkers in Trauma, Injury and Critical Care. Springer International Publishing, Cham"},{"key":"1636_CR115","doi-asserted-by":"publisher","first-page":"119129","DOI":"10.1016\/j.lfs.2021.119129","volume":"276","author":"TE Se","year":"2021","unstructured":"Se TE, Fauzi A, Tang YQ, Chamyuang S, Chia AYY (2021) A review on advances of treatment modalities for Alzheimer\u2019s disease. Life Sci 276:119129","journal-title":"Life Sci"},{"key":"1636_CR116","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-161088","volume":"57","author":"E T\u00f6nnies","year":"2017","unstructured":"T\u00f6nnies E, Trushina E (2017) Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease. J Alzheimers Dis 57:1105\u20131121","journal-title":"J Alzheimers Dis"},{"key":"1636_CR117","first-page":"439","volume":"10","author":"JT Trevino","year":"2020","unstructured":"Trevino JT, Quispe RC, Khan F, Novak V (2020) Non-invasive strategies for nose-to-brain drug delivery. J Clin Trials 10:439","journal-title":"J Clin Trials"},{"key":"1636_CR118","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1126\/science.2200121","volume":"249","author":"C Tuerk","year":"1990","unstructured":"Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505\u2013510","journal-title":"Science"},{"key":"1636_CR119","doi-asserted-by":"publisher","first-page":"173554","DOI":"10.1016\/j.ejphar.2020.173554","volume":"887","author":"M Vaz","year":"2020","unstructured":"Vaz M, Silvestre S (2020) Alzheimer\u2019s disease: recent treatment strategies. Eur J Pharmacol 887:173554","journal-title":"Eur J Pharmacol"},{"key":"1636_CR120","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/10408363.2019.1678011","volume":"57","author":"B Veerabhadrappa","year":"2020","unstructured":"Veerabhadrappa B, Delaby C, Hirtz C, Vialaret J, Alcolea D, Lle\u00f3 A, Fortea J, Santosh MS, Choubey S, Lehmann S (2020) Detection of amyloid beta peptides in body fluids for the diagnosis of Alzheimer\u2019s disease: where do we stand? Crit Rev Clin Lab Sci 57:99\u2013113","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1636_CR121","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1080\/10717544.2021.1937383","volume":"28","author":"MM Wen","year":"2021","unstructured":"Wen MM, Ismail NIK, Nasra MMA, El-Kamel AH (2021) Repurposing ibuprofen-loaded microemulsion for the management of Alzheimer\u2019s disease: evidence of potential intranasal brain targeting. Drug Deliv 28:1188\u20131203","journal-title":"Drug Deliv"},{"key":"1636_CR122","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/14728222.2017.1267142","volume":"21","author":"MR Wilson","year":"2017","unstructured":"Wilson MR, Zoubeidi A (2017) Clusterin as a therapeutic target. Expert Opin Ther Targets 21:201\u2013213","journal-title":"Expert Opin Ther Targets"},{"key":"1636_CR123","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.brainres.2008.01.039","volume":"1200","author":"B Wilson","year":"2008","unstructured":"Wilson B, Samanta MK, Santhi K, Kumar KPS, Paramakrishnan N, Suresh B (2008) Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer\u2019s disease. Brain Res 1200:159\u2013168","journal-title":"Brain Res"},{"key":"1636_CR124","doi-asserted-by":"publisher","first-page":"102176","DOI":"10.1016\/j.jddst.2020.102176","volume":"61","author":"B Wilson","year":"2021","unstructured":"Wilson B, Mohamed ABN, Geetha KM, Jenita JL (2021) Chitosan nanoparticles to enhance nasal absorption and brain targeting of sitagliptin to treat Alzheimer\u2019s disease. J Drug Deliv Sci Technol 61:102176","journal-title":"J Drug Deliv Sci Technol"},{"key":"1636_CR125","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1517\/17425240802542690","volume":"5","author":"B Winblad","year":"2008","unstructured":"Winblad B, Machado JC (2008) Use of rivastigmine transdermal patch in the treatment of Alzheimer\u2019s disease. Expert Opin Drug Deliv 5:1377\u20131386","journal-title":"Expert Opin Drug Deliv"},{"key":"1636_CR126","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ejpb.2011.10.012","volume":"80","author":"H Wu","year":"2012","unstructured":"Wu H, Li J, Zhang Q, Yan X, Guo L, Gao X, Qiu M, Jiang X, Lai R, Chen H (2012) A novel small Odorranalectin-bearing cubosomes: preparation, brain delivery and pharmacodynamic study on amyloid-\u03b225\u201335-treated rats following intranasal administration. Eur J Pharm Biopharm 80:368\u2013378","journal-title":"Eur J Pharm Biopharm"},{"key":"1636_CR127","doi-asserted-by":"publisher","first-page":"6811","DOI":"10.1021\/jm100509v","volume":"53","author":"W Xia","year":"2010","unstructured":"Xia W, Low PS (2010) Folate-targeted therapies for cancer. J Med Chem 53:6811\u20136824","journal-title":"J Med Chem"},{"key":"1636_CR128","doi-asserted-by":"publisher","first-page":"796867","DOI":"10.3389\/fimmu.2021.796867","volume":"12","author":"J Xie","year":"2022","unstructured":"Xie J, van Hoecke L, Vandenbroucke RE (2022) The impact of systemic inflammation on Alzheimer\u2019s disease pathology. Front Immunol 12:796867","journal-title":"Front Immunol"},{"key":"1636_CR129","doi-asserted-by":"publisher","first-page":"103631","DOI":"10.1016\/j.jddst.2022.103631","volume":"75","author":"M Yasir","year":"2022","unstructured":"Yasir M, Zafar A, Noorulla KM, Tura AJ, Sara UVS, Panjwani D, Khalid M, Haji MJ, Gobena WG, Gebissa T, Dalecha DD (2022) Nose to brain delivery of donepezil through surface modified NLCs: formulation development, optimization, and brain targeting study. J Drug Deliv Sci Technol 75:103631","journal-title":"J Drug Deliv Sci Technol"},{"key":"1636_CR130","doi-asserted-by":"publisher","first-page":"1804492","DOI":"10.1002\/adfm.201804492","volume":"28","author":"C Zhang","year":"2018","unstructured":"Zhang C, Wu W, Li RQ, Qiu WX, Zhuang ZN, Cheng SX, Zhang XZ (2018) Peptide-based multifunctional nanomaterials for tumor imaging and therapy. Adv Func Mater 28:1804492","journal-title":"Adv Func Mater"},{"key":"1636_CR131","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4161\/cam.5.4.16986","volume":"5","author":"Z-D Zhou","year":"2011","unstructured":"Zhou Z-D, Chan CH-S, Ma Q-H, Xu X-H, Xiao Z-C, Tan E-K (2011) The roles of amyloid precursor protein (APP) in neurogenesis. Cell Adh Migr 5:280\u2013292","journal-title":"Cell Adh Migr"},{"key":"1636_CR132","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/molecules21010072","volume":"21","author":"TB Zou","year":"2016","unstructured":"Zou TB, He TP, Li HB, Tang HW, Xia EQ (2016) The structure-activity relationship of the antioxidant peptides from natural proteins. Molecules 21:72","journal-title":"Molecules"},{"key":"1636_CR133","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clinbiochem.2019.04.015","volume":"72","author":"M Zv\u011b\u0159ov\u00e1","year":"2019","unstructured":"Zv\u011b\u0159ov\u00e1 M (2019) Clinical aspects of Alzheimer\u2019s disease. Clin Biochem 72:3\u20136","journal-title":"Clin Biochem"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01636-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01636-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01636-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T22:40:26Z","timestamp":1740091226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01636-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":133,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1636"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01636-3","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest, financial or otherwise.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}}]}}